BioAtla Investor Presentation Deck
Leadership Team
Jay Short, Ph.D.
Chairman, CEO and Cofounder
bicatla
STRATAGENE
DIVERSA
HARNESSING THE POWER OF ENZYMES
lli Bristol Myers Squibb IPSEN
life
Bin Zhang, M.D.
Sr. VP, Clinical Development.
technologies
PYXIS
ONCOLOGY
Richard Waldron, M.B.A.
Chief Financial Officer
INTREXON GeneMedicine, Inc. COWEN
AND COMPANY
William Boyle, Ph.D.
Sr. Research Fellow
Anaptys Bio AMGEN salk
Where cures begin.
Eric Sievers, M.D.
Chief Medical Officer
OSeattleGenetics ZYMOGENETICS
A Bristol-Myers Squibb Company
Monica Sullivan
Sr. VP, Intellectual Property & Contracts
STRATAGENE
FRED HUTCH
CURES START HERE"
DIVERSA
BARNESSING THE POWER OF ENZYMES
CapalP
Sheri Lydick
Chief Commercial Officer
Celgenel Bristol Myers Squibb™ ALTANA
Susie Melody
Sr. VP, Human Resources
senomyx
Biogen
BCG
BioAtla| Overview
4View entire presentation